|
|
|
Life Sciences Technology Practice Group -
Industry Intelligence & Publications |
|
Featured Articles & Publications:
Industry Intelligence:
DHR’s extensive research and thought leadership has revealed the following
global trends within the Life Sciences Technology market:
-
Several medical device markets should be reinvigorated by new product launches
during the next year. The most promising areas are in the interventional
cardiology and spinal implant markets.
-
Implantable cardioverter defibrillators: the $1.7 billion ICD market continues
to be one of the fastest-growing market segments.
-
The emergence of a new pharmaceutical category, drug design, could
significantly reduce time to market and discovery cost.
-
Many stent/device companies are focused on drug delivery.
-
Diagnostic and device companies will seek executive sales talent built on a
scientific foundation.
-
Orthopedics remains a leading medical device sector. The total orthopedic drug,
implant and device market is expected to reach $74.1 billion by 2009.
-
Spinal implants account for $1.4 billion of the orthopedic market, and are
growing by more than 20% annually.
-
Converging technologies will drive companies to create markets before product
commercialization.
-
Surgical robotics are on the cusp of revolutionizing operative capabilities.
Increased usage of 3-D imaging technology to enhance and improve standard
radiological images.
-
Biotechnology companies must focus on the development and advancement of new
technologies that will improve the quality and speed of bringing drugs to
market.
-
Genomics and proteomics will continue to be the fast-growth areas for drug
development and new technologies.
-
Early stage device companies have typically been acquired rather that going
public. Acquisition will be most likely liquidity event.
-
Emerging biotech corridors will stimulate incremental investments and long term
revenue growth.
|
|
|
